The DOI matches its Crossref record; 112 of the 114 references it cites were found in a registry or an index, and 2 are not checked yet; 11 of the 126 sources its claims cite were checked for support.
Bone loss after bariatric surgery: causes, consequences, and management
Open accessAbstract
Bariatric surgery is an effective and increasingly common treatment for severe obesity and its many comorbidities. The side-effects of bariatric surgery can include detrimental effects on bone and mineral metabolism. Bone disease in patients who have had bariatric surgery is affected by preoperative abnormalities in bone and mineral metabolism related to severe obesity. Changes that arise after bariatric surgery are specific to procedure type: the most pronounced abnormalities in calciotropic hormones and bone loss are noted after procedures that result in the most malabsorption. The most consistent site for bone loss after all bariatric procedures is at the hip. There are limitations of dual-energy x-ray absorptiometry technology in this population, including artefact introduced by adipose tissue itself. Bone loss after bariatric surgery is probably multifactorial. Proposed mechanisms include skeletal unloading, abnormalities in calciotropic hormones, and changes in gut hormones. Few data for fracture risk in the bariatric population are available, and this is a crucial area for additional research. Treatment should be geared toward correction of nutritional deficiencies and study of bone mineral density in high-risk patients. We explore the skeletal response to bariatric surgery, potential mechanisms for changes, and strategies for management.
Verified 2026-10-06 · 2 references not checked yet
Overview
CoChat Summary
TL;DR
This narrative review examines how bariatric surgery affects bone and mineral metabolism, concluding that skeletal effects vary by procedure type and are most severe after malabsorptive operations. It argues that bone loss is multifactorial, that fracture-risk data remain scarce, and that management should focus on correcting nutritional deficiencies and monitoring bone density in high-risk patients.
Key findings
- Bone loss is procedure-specific and tracks with degree of malabsorption: hip BMD declines of roughly 8–11% in the first year after Roux-en-Y gastric bypass, versus variable or absent hip change after purely restrictive gastric banding (reported estimates ranging from no change at 1 year to 6% at 24 months).
- The hip is the most consistently affected site across procedures, while spine changes are more variable; the authors attribute part of this pattern to PTH's catabolic effect on cortical bone and anabolic effect on cancellous bone.
- Calciotropic abnormalities are common and often persist despite supplementation: after RYGB, 25OHD stayed stable despite vitamin D intake rising from a mean of 658 IU/day at baseline to 1698 IU/day at 12 months, and no rise in 25OHD occurred at doses near 5000 IU daily. After BPD/DS, over half of patients had vitamin D deficiency and secondary hyperparathyroidism estimates ranged from 60–100%.
- Fracture data are sparse: a UK retrospective cohort of 2079 surgical patients versus 10442 matched controls found no significant increase over a mean 2.2 years, though a trend appeared at 3–5 years; a separate historical cohort (median 7.7 years, 258 subjects, mostly RYGB) showed excess fractures, with half occurring in the foot, leg, or hand.
Methods
- Narrative review; literature identified via PubMed and Ovid MEDLINE searches combining "bariatric surgery" and "bone," prioritizing publications from the preceding five years plus frequently cited older work and reference-list hand-searching.
- Emphasis on prospective data and on BMD measured at the WHO diagnostic sites (lumbar spine, total hip, femoral neck, 1/3 radius); gut hormone and adipokine biology was deliberately excluded as recently reviewed elsewhere.
- Findings are organized by procedure (gastric banding, sleeve gastrectomy, RYGB, BPD/DS), then by proposed mechanism (unloading, calcium/vitamin D/PTH, other hormones), microarchitecture, fracture risk, and management.
Limitations
- Stated by the paper: most included studies are small with substantial dropout, especially beyond one year; heterogeneity in patient age, sex, and race, surgical technique, and DXA methods; calcium and vitamin D supplementation is usually ancillary and adherence is unmeasured or unreported.
- Stated by the paper: DXA accuracy and precision are compromised by obesity and by changes in fat mass, and the ~136 kg weight limit of many scanners restricted axial measurements to subsets of patients, reducing power; QCT and HR-pQCT may be less affected but are not immune to subcutaneous fat effects.
- Evident from the text: the review itself is not systematic, so selection of cited studies is judgment-based; several key comparisons (e.g., RYGB versus sleeve gastrectomy) rest on single small studies, and the authors repeatedly note that no prospective fracture data exist.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 7 Not valid · 46 Not checked · 30 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“Hyperparathyroidism is common, and while this may be secondary to vitamin D deficiency, an independent relationship between PTH and obesity has been reported14, 15.”
§ Bone Loss After Bariatric Surgery: Causes, Consequences and Management > Causes of Abnormal Bone Metabolism In Obese Individuals
What the sources say
- Could not verifycites [14] Hyppönen, 2007, Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors, Am J Clin Nutr sourceExperimental — accuracy not yet measured
The Introduction mentions parathyroid hormone only as an outcome used to define optimal vitamin D status. Table 2 and the conclusions report the prevalence of hypovitaminosis D, not hyperparathyroidism. Searches for hyperparathyroidism and PTH prevalence found no passage establishing that hyperparathyroidism is common. (LLM, conf=0.76)
- Not checked yetcites [15] Compston, 1981, Vitamin D status and bone histomorphometry in gross obesity, Am J Clin Nutr source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Measurements by QCT34 and high resolution peripheral QCT (HR-pQCT)35 may be less affected by changes in body fat.”
§ Bone Loss After Bariatric Surgery: Causes, Consequences and Management > Limitations of Bone Studies in the Bariatric Population
What the sources say
- Supportedcites [34] Yu, 2012, Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT, J Bone Miner Res source
The Discussion (Yu et al. 2012) states directly that 'QCT BMD is less affected than DXA BMD by simulated increases in body fat,' with better reproducibility after fat layering, and the Abstract Conclusions add that although overlying fat also affects QCT, the error is smaller and more uniform than with DXA. Results (Human studies) quantify this: spine trabecular QCT rose only 1.5 ± 2.5% with a narrower error range (95% CI −3.4 to +6.4%) than DXA spine. This citation is attached to the QCT arm of the sentence (the HR-pQCT arm carries a separate reference), and the hedged 'may be less affected' matches the source's own confidence; note the source's evidence is from simulated fat layering at the lumbar spine only, and it explicitly cautions against generalizing to femoral sites. (LLM, conf=0.90)
- Not checked yetcites [35] Knapp, 2012, Obesity increases precision errors in dual-energy X-ray absorptiometry measurements, J Clin Densitom source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Resorption markers increase steadily by up to 200% over the first 12-18 months 52, 63, 64.”
§ Bone Loss After Bariatric Surgery: Causes, Consequences and Management > Skeletal Consequences of Bariatric Surgery > Roux-en-Y gastric Bypass
What the sources say
- Could not verifycites [52] Hutter, 2011, First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass, Ann Surg sourceExperimental — accuracy not yet measured
The Results sections on weight reduction and comorbidities report BMI and clinical outcomes after bariatric surgery, not bone-resorption markers. Searches for resorption markers, bone turnover, a 200% increase, and the 12–18-month period found no passage in our copy addressing the claimed trend after RYGB. Page numbers were not available. (LLM, conf=0.78)
- Not checked yetcites [63] Yu, 2013, Bone loss after bariatric surgery: discordant results between DXA and QCT bone density, J Bone Miner Res
- Partly supportedcites [64] Bruno, 2010, Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
The tables on pp. 3–4 show that serum NTX, a resorption marker, increased after RYGB: the group mean rose from 10.9 to 19.6 at six months and from 10.8 to 16.9 at 18 months. The Statistical analyses section (p. 3) says the increases in the two groups were not significantly different. These findings support an increase, but not a steady rise through 18 months or an increase of 200% in this study. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Relative to body weight, microarchitecture and strength are lower in obese women compared to controls 23.”
§ Bone Loss After Bariatric Surgery: Causes, Consequences and Management > Causes of Abnormal Bone Metabolism In Obese Individuals
What the sources say
- Partly supportedcites [23] Gilsanz, 2009, Reciprocal relations of subcutaneous and visceral fat to bone structure and strength, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
Gilsanz et al. (2009) do report that, after adjusting for leg length and thigh musculature, visceral fat is negatively associated with femoral cross-sectional area, cortical bone area and the principal/polar moments (strength) in women (Abstract p. 1; Discussion p. 3), which covers the 'relative to body size, strength is lower' element. But there is no obese-versus-control comparison: the 100 subjects were healthy, sexually and skeletally mature females aged 15–25 yr with weights restricted to the 3rd–97th percentiles precisely 'to minimize the confounding effects of obesity' (Subjects p. 2; Discussion p. 5; Table 1 p. 3 shows mean BMI 24.2, range 16.8–34.2). The paper also does not assess microarchitecture (only CT-derived femoral cross-sectional dimensions and strength indices), and its overall conclusion is reciprocal — subcutaneous fat is beneficial to bone structure and strength (Conclusions p. 1; Discussion p. 5) — so the blanket attribution of lower structure and strength in obese women is not supported. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Declines in hip BMD range between 8-11%17, 52-54, 62, 67-69.”
§ Bone Loss After Bariatric Surgery: Causes, Consequences and Management > Skeletal Consequences of Bariatric Surgery > Roux-en-Y gastric Bypass
What the sources say
- Not checked yetcites [17] Grethen, 2012, Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity, J Clin Endocrinol Metab source
- Could not verifycites [52] Hutter, 2011, First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass, Ann Surg sourceExperimental — accuracy not yet measured
The Results section, under “Reductions in Weight,” reports BMI changes after RYGB, not hip bone mineral density. Searches for hip BMD and bone density found no passage in our copy reporting an 8–11% decline. Page numbers were not available. (LLM, conf=0.76)
- Not checked yetcites [53] Demaria, 2010, Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database, Ann Surg source
- Partly supportedcites [54] Pluskiewicz, 2012, Bone mineral changes in spine and proximal femur in individual obese women after laparoscopic sleeve gastrectomy: a short-term study, Obes Surg sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports hip bone-mass loss after RYGB in a small comparison study. It does not give an 8–11% range for hip BMD decline; the numerical results for this paper’s own patients concern sleeve gastrectomy, not RYGB. (LLM, conf=0.88)
- Not checked yetcites [62] Vilarrasa, 2011, Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up, Obes Surg source
- Not checked yetcites [67] Carrasco, 2009, Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery, Obes Surg source
- Not checked yetcites [68] Vilarrasa, 2009, Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss, Obes Surg source
- Not checked yetcites [69] Pereira, 2007, Impact of marked weight loss induced by bariatric surgery on bone mineral density and remodeling, Braz J Med Biol Res source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims · 2 with their cited sources checked
Create a free account to see all 89 claims and to verify the 115 references still open.
- It may state two separate claims as one. 27
- Probably not a substantial claim. 7
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Bone Loss After Bariatric Surgery: Causes, Consequences and Management > Changes in Bone Quality and Microarchitecture After Bariatric Surgery
“The sub-group of RYGB patients lost more weight, had more cortical bone loss than those with GB or SG and had declines in cortical load share estimated by finite element analysis84.”
§ Bone Loss After Bariatric Surgery: Causes, Consequences and Management > References
“84. Lalmohamed A de Vries F Bazelier MT Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study Bmj 2012 345 e5085 22867649 10.1136/bmj.e5085 PMC3413006”
Citations
Cites
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Decreased bioavailability of vitamin D in obesity
Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., & Holick, M. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.690 · Cited by 3,204
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Hip contact forces and gait patterns from routine activities
Bergmann, G., Deuretzbacher, G., Heller, M., Graichen, F., Rohlmann, A., Strauss, J., & Duda, G. N. (2001) · Journal of Biomechanics · doi:10.1016/s0021-9290(01)00040-9 · Cited by 2,215
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Bone “mass” and the “mechanostat”: A proposal
Frost, H. M. (1987) · The Anatomical Record · doi:10.1002/ar.1092190104 · Cited by 2,132
Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Mechanick, J. I., Youdim, A., Jones, D. B., Garvey, W. T., Hurley, D. L., McMahon, M. M., Heinberg, L. J., Kushner, R., Adams, T. D., Shikora, S., et al. (2013) · Obesity · doi:10.1002/oby.20461 · Cited by 1,650
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol
Heaney, R. P., Davies, K. M., Chen, T. C., Holick, M. F., & Barger-Lux, M. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.204 · Cited by 1,396
Research works printed but not linked: 1
- Yu, 2012, Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT, J Bone Miner Res, 27, 119, 10.1002/jbmr.506 · DOI · Paper page
Cited by
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Lingvay, I., Cohen, R. V., Roux, C. W. L., & Sumithran, P. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01210-8 · Cited by 433
Mechanick, J. I., Apovian, C., Brethauer, S., Timothy Garvey, W., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 389
Obesity and Bone: A Complex Relationship
Rinonapoli, G., Pace, V., Ruggiero, C., Ceccarini, P., Bisaccia, M., Meccariello, L., & Caraffa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413662 · Cited by 261
Metadata
- Authors
- Stein, E. M., & Silverberg, S. J.
- Affiliations
- Columbia University Irving Medical Center (US)
- Columbia University (US)
- Corresponding author
- Stein, Emily M
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 2
- Issue
- 2
- Pages
- 165-174
- ISSN
- 2213-8587 (ISSN-L)
- PMC
- PMC4467779
- OpenAlex
- W2151731752
- Cited by
- 199
- References
- 113
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 10 · 2022: 23 · 2021: 21 · 2020: 23 · 2019: 26 · 2018: 15 · 2017: 11 · 2016: 14 · 2015: 9 · 2014: 5
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- (EMS) (K23 DK084337)
- (SJS) (K24 DK074457)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- bariatric surgery, bone loss, morbid obesity, bone mineral metabolism, hip bone loss, calciotropic hormones, malabsorption, skeletal unloading, gastrointestinal hormones, fracture risk, nutritional deficiency, bone mineral density
- MeSH terms
- Bone Resorption, Humans, Weight Loss, Bone Density, Malnutrition, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone loss after bariatric surgery: causes, consequences, and management. https://app.cochat.ai/papers/10.1016/s2213-8587(13)70183-9
- The paper
- Stein, E. M., & Silverberg, S. J. (2014). Bone loss after bariatric surgery: causes, consequences, and management. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(13)70183-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.